Saturday, August 29, 2026 SourcesAbout🌓
🇨🇦 CA ▾
BREAKING
Latest

AbCellera launches $200-million equity offering on heels of strong menopause trial results

The Globe and Mail ·
AbCellera launches $200-million equity offering on heels of strong menopause trial results

Vancouver biotech’s stock hit the highest level since early 2023 this week and is up 185% this year

Read the full article on The Globe and Mail ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.theglobeandmail.com — the content belongs to The Globe and Mail.

More from The Globe and Mail

See all ›

More in Latest

See all ›